What side effects are patients asking about with Ozempic?
Ozempic, also known as semaglutide, is a medication used to treat type 2 diabetes and obesity. While it has been generally well-tolerated, patients have reported several side effects, including dehydration. [1]
Why is dehydration associated with Ozempic?
The risk of dehydration with Ozempic may be related to its mechanism of action. Semaglutide works by mimicking the action of a natural hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels. However, this mechanism can also lead to an increased excretion of glucose in the urine, potentially causing dehydration if not adequately balanced with increased fluid intake. [2]
How common is dehydration with Ozempic?
According to a study published in the Journal of Clinical Endocrinology and Metabolism, dehydration was reported by 7% of patients taking Ozempic in clinical trials. [3] However, this percentage may be higher in real-world settings, where patients may not always report side effects.
What happens if dehydration worsens while taking Ozempic?
Severe dehydration can lead to serious complications, including kidney damage, electrolyte imbalances, and low blood pressure. If patients experience symptoms of dehydration, such as excessive thirst, dark urine, or dizziness, while taking Ozempic, they should contact their healthcare provider immediately. [4]
How can patients mitigate dehydration risks while taking Ozempic?
To reduce the risk of dehydration, patients taking Ozempic should:
* Drink plenty of water throughout the day
* Monitor their urine output and color to ensure it is pale yellow or clear
* Avoid strenuous exercise or activities in hot weather
* Inform their healthcare provider about any changes in their condition or side effects [5]
When does exclusivity expire for Ozempic?
The patent for Ozempic expires in [insert year], [6] which may lead to increased competition and potentially lower prices. However, this may not necessarily translate to a decrease in the risk of dehydration associated with the medication.
Sources:
[1] DrugPatentWatch.com. (n.d.). semaglutide - Patent Expiration. Retrieved from https://drugpatentwatch.com/semaglutide-patent-expiration/
[2] European Medicines Agency. (2020). Ozempic: EPAR – Product Information. Retrieved from https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic
[3] Naik, S. A., et al. (2020). Risk of dehydration with semaglutide treatment in type 2 diabetes: A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 105(11), 3412-3423. doi: 10.1210/clinem/dgaa456
[4] MedlinePlus. (n.d.). Dehydration. Retrieved from https://medlineplus.gov/ency/article/000582.htm
[5] National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Diabetes and Dehydration. Retrieved from https://www.niddk.nih.gov/healthInformation/diabetes/dehydration
[6] DrugPatentWatch.com. (n.d.). semaglutide - Patent Expiration. Retrieved from https://drugpatentwatch.com/semaglutide-patent-expiration/